drugset
drugset / Trial / NCT04421716

Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid

NCT04421716 ↗

Phase 0 Completed 18 enrolled The University of Texas Health Science Center at San Antonio
Non-randomizedCrossoverOpen-labelBasic science

Summary

The primary objective of this research is to investigate the bioavailability of curcumin (CURC) and ursolic acid (UA) in a phase I clinical trial in healthy men and obtain biological material for bioavailability analysis.

Timeline

Start
2020-10-20
Primary completion
2020-11-30
Completion
2021-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 600 mg —
Subject Ursolic Acid Small molecule 150 mg —

Indications

No indication recorded.